Showing results (141-150 of 174) with videos related to
Sort By:
Pageof 18
Clinical Chemistry and Laboratory Medicine|July 28, 2010
Development and description of GETT: a genetic testing evidence tracking toolFrançois Rousseau, Carmen Lindsay, Marc Charland, et al.The Canadian Journal of Cardiology|June 26, 2016
Diagnosis, Prevention, and Management of Statin Adverse Effects and Intolerance: Canadian Consensus Working Group Update (2016)G B John Mancini, Steven Baker, Jean Bergeron, et al.The Journal of Clinical Endocrinology and Metabolism|June 15, 2006
Visceral adiposity and endothelial lipaseMarie-Eve Paradis, Karen O Badellino, Daniel J Rader, et al.Circulation|May 9, 2002
Familial aggregation of blood lipid response to exercise training in the health, risk factors, exercise training, and genetics (HERITAGE) Family StudyTreva Rice, Jean-Pierre Després, Louis Pérusse, et al.The Canadian Journal of Cardiology|November 26, 2013
Diagnosis, prevention, and management of statin adverse effects and intolerance: Canadian Working Group Consensus updateG B John Mancini, A Yashar Tashakkor, Steven Baker, et al.Lancet (London, England)|March 7, 2015
Anacetrapib as lipid-modifying therapy in patients with heterozygous familial hypercholesterolaemia (REALIZE): a randomised, double-blind, placebo-controlled, phase 3 studyJohn J P Kastelein, Joost Besseling, Sukrut Shah, et al.European Journal of Endocrinology|July 26, 2019
Effects of 6-month vitamin D supplementation on insulin sensitivity and secretion: a randomised, placebo-controlled trialPatricia Lemieux, S John Weisnagel, Annabelle Z Caron, et al.Cardiology and Therapy|October 7, 2023
Real-World Insights into Evolocumab Use in Patients with Hyperlipidemia Across Five Countries: Analysis from the ZERBINI StudyMilan Gupta, Rajvi J Wani, Khalid Al Faraidy, et al.Journal of Clinical Lipidology|July 26, 2025
Patient experience with familial chylomicronemia syndrome before and after olezarsen treatment: Qualitative interviews with clinical trial participantsAsia Sikora Kessler, T Michelle Brown, Emily Bratlee-Whitaker, et al.The Canadian Journal of Cardiology|November 14, 2021
Influence of the LDL-Receptor Genotype on Statin Response in Heterozygous Familial Hypercholesterolemia: Insights From the Canadian FH RegistryGabrielle Roy, Patrick Couture, Jacques Genest, et al.Pageof 18